# CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 P&L / Income Statement

- Company: CASTLE BIOSCIENCES, INC. (CSTL)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0001628280-26-051052
- Page: https://plicit.ai/financials/cstl/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/cstl-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **NET REVENUES**: 103,546,000 US dollars
- **Operating expenses (calculated)**: 106,616,000 US dollars
- **Operating loss**: negative 3,070,000 US dollars
- **Other income (expense), net (calculated)**: 1,380,000 US dollars
- **Loss before income taxes**: negative 1,690,000 US dollars
- **Income tax expense (benefit)**: 370,000 US dollars
- **Net (loss) income**: negative 2,060,000 US dollars
- **Dermatologic**: 48,704,000 US dollars
- **Non-Dermatologic**: 54,842,000 US dollars
- **Total operating expenses, net**: 106,616,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.